YARW
Yarrow Bioscience Inc
NASDAQ · Healthcare · Biotechnology · US
$29.29
−4.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 134.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.54x
- Price / sales
- 162.23x
- Price / cash flow
- -4.62x
Enterprise value
- Enterprise value
- $55.3M
- EV / sales
- 114.67x
- EV / EBITDA
- -2.93x
- EV / EBIT
- -2.77x
- Market cap
- $78.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026